| Patent | Date |
|---|
Methods of synthesizing a difluorolactam analog
Grant 11,345,690 - Barrett , et al. May 31, 2 | 2022-05-31 |
Methods Of Synthesizing A Difluorolactam Analog
App 20220127252 - Barrett; Stephen Douglas ; et al. | 2022-04-28 |
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Grant 11,066,361 - Barrett , et al. July 20, 2 | 2021-07-20 |
Methods, systems, and compositions for promoting bone growth
Grant 10,729,810 - Barrett , et al. | 2020-08-04 |
Difluorolactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20200207709 - Barrett; Stephen Douglas ; et al. | 2020-07-02 |
Difluorolactam compounds as EP.sub.4 receptor-selective agonists for use in the treatment of EP.sub.4-mediated diseases and conditions
Grant 10,556,862 - Barrett , et al. Feb | 2020-02-11 |
Methods Of Synthesizing A Difluorolactam Analog
App 20190202816 - Barrett; Stephen Douglas ; et al. | 2019-07-04 |
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions
App 20190144435 - Barrett; Stephen Douglas ; et al. | 2019-05-16 |
Difluorolactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20190092722 - Barrett; Stephen Douglas ; et al. | 2019-03-28 |
Methods Of Synthesizing A Difluorolactam Analog
App 20180170918 - Barrett; Stephen Douglas ; et al. | 2018-06-21 |
Methods of synthesizing a difluorolactam analog
Grant 9,914,725 - Barrett , et al. March 13, 2 | 2018-03-13 |
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Condtions
App 20170260173 - Barrett; Stephen Douglas ; et al. | 2017-09-14 |
Difluorolactam compositions for EP.sub.4-mediated osteo related diseases and conditions
Grant 9,701,630 - Barrett , et al. July 11, 2 | 2017-07-11 |
Lactam compounds as EP.sub.4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Grant 9,688,627 - Barrett , et al. June 27, 2 | 2017-06-27 |
Difluorolactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20170066751 - Barrett; Stephen Douglas ; et al. | 2017-03-09 |
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions
App 20160340306 - Barrett; Stephen Douglas ; et al. | 2016-11-24 |
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Grant 9,487,478 - Barrett , et al. November 8, 2 | 2016-11-08 |
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions
Grant 9,440,919 - Barrett , et al. September 13, 2 | 2016-09-13 |
Methods, Systems, And Compositions For Promoting Bone Growth
App 20160158413 - Barrett; Stephen Douglas ; et al. | 2016-06-09 |
Methods Of Synthesizing A Difluorolactam Analog
App 20160060253 - Barrett; Stephen Douglas ; et al. | 2016-03-03 |
Lactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20160060216 - Barrett; Stephen Douglas ; et al. | 2016-03-03 |
Difluorolactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20160024006 - Barrett; Stephen Douglas ; et al. | 2016-01-28 |
Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
Grant 9,180,116 - Barrett , et al. November 10, 2 | 2015-11-10 |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D.sub.2 mediated diseases
Grant 9,126,973 - Endres , et al. September 8, 2 | 2015-09-08 |
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions
App 20150174099 - Barrett; Stephen Douglas ; et al. | 2015-06-25 |
Difluorolactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions
App 20150175538 - Barrett; Stephen Douglas ; et al. | 2015-06-25 |
Multiheteroaryl Compounds As Inhibitors Of H-pgds And Their Use For Treating Prostaglandin D2 Mediated Diseases
App 20150099748 - Endres; Gregory W. ; et al. | 2015-04-09 |
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
Grant 8,536,185 - Endres , et al. September 17, 2 | 2013-09-17 |
Multiheteroaryl Compounds As Inhibitors Of H-pgds And Their Use For Treating Prostaglandin D2 Mediated Diseases
App 20130079375 - Endres; Gregory W. ; et al. | 2013-03-28 |
Multiheteroaryl Compounds As Inhibitors Of H-pgds And Their Use For Treating Prostaglandin D2 Mediated Diseases
App 20100075990 - Endres; Gregory W. ; et al. | 2010-03-25 |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyprimidines as inhibitors of cellular proliferation
Grant 7,501,425 - Dobrusin , et al. March 10, 2 | 2009-03-10 |
Pteridinones As Kinase Inhibitors
App 20070049600 - Denny; William Alexander ; et al. | 2007-03-01 |
Pteridinones as kinase inhibitors
Grant 7,169,778 - Denny , et al. January 30, 2 | 2007-01-30 |
2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
Grant 7,022,711 - Hamby , et al. April 4, 2 | 2006-04-04 |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
App 20040044012 - Dobrusin, Ellen Myra ; et al. | 2004-03-04 |
Pyridotriazines and pyridopyridazines
Grant 6,683,183 - Kramer , et al. January 27, 2 | 2004-01-27 |
2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimdin-7-ones
App 20030220345 - Hamby, James Marino ; et al. | 2003-11-27 |
Pteridinones as kinase inhibitors
App 20030130286 - Denny, William Alexander ; et al. | 2003-07-10 |
Pyridotriazines and pyridopyridazines
App 20020061865 - Kramer, James Bernard ; et al. | 2002-05-23 |
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 6,218,388 - Boschelli , et al. April 17, 2 | 2001-04-17 |
Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
Grant 5,990,146 - Boschelli , et al. November 23, 1 | 1999-11-23 |
| 